Drug recall · January 28, 2026
Icosapent Ethyl capsules recall
Why: Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-07
- Lots / codes
Lot # S2520304, S2520333, Exp 2/28/2027; S2540186, Exp 4/30/2027
- Quantity
- 22,896 bottles
- Company
- Zydus Pharmaceuticals (USA) Inc, Pennington, NJ
- Distribution
- US Nationwide.
- Initiated
- December 30, 2025 · Voluntary: Firm initiated
- Classified
- January 22, 2026
- Reported
- January 28, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Icosapent ethyl
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.